TP53 and small cell lung carcinoma: Specifically, the authors observed that in a cohort of 3590 SCLC tumors, 96 were wild-type TP53 (2.7%), 747 were wild-type RB1 (20.8%), and 197 were wild-type for both TP53 and RB1 (5.5%).